Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Praticien hospitalier
Marseille 9e Arrondissement (13274)
Revue / méta-analyse · Corticothérapie · Essai clinique
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
2023Rheumatology (Oxford, England)
PubMed ↗Absence of overexpression of KIR3DL2 on CD4+ T cells and NK cells in patients with axial spondyloarthritis
2017AIDS (London, England)
PubMed ↗Frailty in HIV infected people: a new risk factor for bone mineral density loss
2016Joint bone spine
PubMed ↗Bone infarcts: Unsuspected gray areas?
2010Osteoarthritis and cartilage
PubMed ↗Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials
2010Rheumatology (Oxford, England)
PubMed ↗Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysis
2016RMD open
PubMed ↗Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database
2010Osteoarthritis and cartilage
PubMed ↗Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled trials
2025JBMR plus
PubMed ↗Real-world efficacy and safety of burosumab in tumor-induced osteomalacia: case series from an early access program
2025Article
Real-world efficacy and safety of Burosumab in tumor-induced Osteomalacia: case series from an early access program
JBMR Plus
2023Article
Absence of overexpression of KIR3DL2 on CD4+ T cells and NK cells in patients with axial spondyloarthritis
Rheumatology
2023Article
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study
Digestive and Liver Disease
2021Article
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
The Lancet Rheumatology
2020Article
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
Annals of the Rheumatic Diseases
2017Article
Frailty in HIV infected people: a new risk factor for bone mineral density loss
AIDS. Official journal of the international AIDS Society
2016Article
Bone infarcts: Unsuspected gray areas?
Joint Bone Spine
2016Article
Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database.
RMD Open : Rheumatic & Musculoskeletal Diseases
Rhumatologues à proximité